Written Question·Department of Health and Social Care·UIN 190164
Trastuzumab Deruxtecan
Tabled: 19 June 2023
Answered: 26 June 2023
Named DayQuestion
Saqib Bhatti
Conservative — Meriden and Solihull East
To ask the Secretary of State for Health and Social Care, whether the National Institute for Health and Care Excellence is taking steps to approve Enhertu for use in the treatment of cancers other than breast cancer.
Answer
Helen WhatelyThe National Institute for Health and Care Excellence (NICE) is currently in the early stages of developing technology appraisal guidance on treatments for non-small-cell lung cancer, including Enhertu (trastuzumab deruxtecan) and held a scoping workshop focusing on this topic on 24 April 2023.